Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Neurodegenerative Disease

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1786966

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1786966

Central Nervous System Therapeutics Market Size, Share, Trends, & Industry Analysis Report, By Disease (Neurovascular Disease, CNS Trauma, Mental Health), By Drug Class, By Distribution Channel, and By Region - Market Forecast, 2025-2034

PUBLISHED:
PAGES: 125 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

Description

Table of Contents

List of Tables

The central nervous system therapeutics market size is expected to reach USD 265.54 Billion by 2034, according to a new study by Polaris Market Research. The report "Central Nervous System Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Disease (Neurovascular Disease, CNS Trauma, Mental Health), By Drug Class, By Distribution Channel, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Central Nervous System (CNS) therapeutics refers to treatments aimed at managing and alleviating disorders affecting the brain, spinal cord, and nerves, such as depression, epilepsy, Parkinson's disease, and Alzheimer's. These therapies include medications, biologics, and emerging digital and precision medicine approaches designed to improve neurological function and quality of life.

An aging population is one of the strongest drivers of the CNS therapeutics market. People become more prone to neurological and mental health conditions like Alzheimer's, Parkinson's, and dementia as people age. These age-related disorders are chronic and progressive, requiring long-term medical attention and treatment. The rise in the elderly population globally in region such as North America, Europe, and parts of Asia is putting pressure on healthcare systems to provide better and more efficient CNS care. Older adults are also more likely to seek medical help and adhere to treatment plans, driving consistent demand for CNS drugs and therapies. In response, pharmaceutical companies are focusing their research efforts on neurodegenerative conditions and age-related cognitive decline. Governments are further increasing funding for elderly healthcare programs, including those targeting CNS disorders. The need for effective, accessible, and safe CNS therapeutics rise as the global senior population continues to grow, thereby driving the growth.

The post-COVID-19 landscape has redefined healthcare priorities, placing greater emphasis on mental well-being and neurological care. The pandemic not only highlighted the vulnerabilities in accessing CNS treatments during health crises but also increased demand for digital therapeutics, remote care models, and innovative approaches to managing chronic neurological conditions. Governments and private organizations are also investing more into CNS research, driven by the growing burden of neurodegenerative and psychiatric illnesses, thereby driving the growth.

Central Nervous System Therapeutics Market Report Highlights

The mental health segment accounted for 26.15% share during the forecast period driven by a global rise in psychiatric conditions such as depression, anxiety, bipolar disorder, and schizophrenia.

The hospital pharmacy segment accounted USD 55.43 billion revenue in 2024 as many CNS treatments, especially for severe mental health or neurovascular conditions, are administered or initiated in hospital settings under close medical supervision.

North America central nervous system therapeutics market accounted for 40.24% global market share in 2024 driven by advanced healthcare infrastructure, high healthcare spending, and widespread awareness of neurological and mental health conditions.

The Asia Pacific central nervous system therapeutics market recorded USD 25.12 billion revenue in 2024, due to its large population, rising healthcare investment, and increasing awareness of neurological disorders.

The global key market players are AstraZeneca plc; Biogen Inc.; Eli Lilly and Company; Johnson & Johnson; Merck & Co., Inc.; Neuraxpharm; Novartis AG; Otsuka Pharmaceutical Co., Ltd; Pfizer Inc.; Takeda Pharma Company Ltd; Teva Pharmaceutical Industries Ltd.

Polaris market research has segmented the central nervous system therapeutics market report based on Disease, drug class, distribution channel, and region:

By Disease (Revenue - USD Billion, 2020-2034)

Neurovascular Diseases

CNS Trauma

Mental Health

Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Multiple Sclerosis

Huntington's Disease

Amyotrophic Lateral Sclerosis

Others

Infectious Diseases

CNS Cancer

Others

By Drug Class (Revenue - USD Billion, 2020-2034)

Anesthetics

Anticonvulsants

Antiemetic

CNS Stimulants

Pain Relievers

Others

By Distribution Channel (Revenue - USD Billion, 2020-2034)

Hospital Pharmacy

Retail Pharmacy

Other

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of APAC

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of MEA

Show more
Product Code: PM5368

Table of Contents

1. Global Central Nervous System Therapeutics Market-Report Overview

  • 1.1. Scope of the report
  • 1.2. Market Segment Analysis
  • 1.3. Regulatory Scenario by Region/Country
  • 1.4. Market Investment Scenario Strategic
  • 1.5. Market Analysis by Disease (USD Million)
    • 1.5.1 Global Central Nervous System Therapeutics Market Share by Disease (2025-2034)
    • 1.5.2 Neurovascular Diseases
    • 1.5.3 CNS Trauma
    • 1.5.4 Mental Health
    • 1.5.5 Neurodegenerative Diseases
      • 1.5.5.1 Alzheimer's Disease
      • 1.5.5.2 Parkinson's Disease
      • 1.5.5.3 Multiple Sclerosis
      • 1.5.5.4 Huntington's Disease
      • 1.5.5.5 Amyotrophic Lateral Sclerosis
      • 1.5.5.6 Others
    • 1.5.6 Infectious Diseases
    • 1.5.7 CNS Cancer
    • 1.5.8 Others
  • 1.6. Global Central Nervous System Therapeutics Market Share by Disease in 2025 & 2034
  • 1.7. Market Analysis by Drug Class (USD Million)
    • 1.7.1 Global Central Nervous System Therapeutics Market Share by Drug Class (2025-2034)
    • 1.7.2 Anesthetics
    • 1.7.3 Anticonvulsants
    • 1.7.4 Antiemetic
    • 1.7.5 CNS Stimulants
    • 1.7.6 Pain Relievers
    • 1.7.7 Others
  • 1.8. Global Central Nervous System Therapeutics Market Share by Drug Class in 2025 & 2034
  • 1.9. Market Analysis by Distribution Channel (USD Million)
    • 1.9.1 Global Central Nervous System Therapeutics Market Share by Distribution Channel (2025-2034)
    • 1.9.2 Hospital Pharmacies
    • 1.9.3 Retail Pharmacies
    • 1.9.4 Others
  • 1.10. Global Central Nervous System Therapeutics Market Share by Distribution Channel in 2025 & 2034

2. driver restraint challenge and opportunities of Central Nervous System Therapeutics Market

  • 2.1. Driver, Restraint, Challenge and Opportunities Analysis
    • 2.1.1 Market Driver Analysis
    • 2.1.2 Market Restraint Analysis
    • 2.1.3 Market Opportunity
    • 2.1.4 Market Challenges

3. Global Growth Trends

  • 3.1. Industry Trends
    • 3.1.1 SWOT Analysis
      • 3.1.1.1 Strengths
      • 3.1.1.2 Weaknesses
      • 3.1.1.3 Opportunities
      • 3.1.1.4 Threats
    • 3.1.2 PESTEL Analysis
      • 3.1.2.1 Political Landscape
      • 3.1.2.2 Economic Landscape
      • 3.1.2.3 Social Landscape
      • 3.1.2.4 Technological Landscape
      • 3.1.2.5 Environmental Landscape
      • 3.1.2.6 Legal Landscape
    • 3.1.3 Porter's Five Forces Analysis
      • 3.1.3.1 Bargaining Power of Suppliers
      • 3.1.3.2 Bargaining Power of Buyers
      • 3.1.3.3 Threat of Substitute
      • 3.1.3.4 Threat of New Entrant
      • 3.1.3.5 Competitive Rivalry
  • 3.2. Potential Market and Growth Potential Analysis

4. Covid-19 Impact

  • 4.1. Covid-19 Impact
  • 4.2. COVID V, U, W and L Analysis
    • 4.2.1 COVID V Analysis
    • 4.2.2 COVID U Analysis
    • 4.2.3 COVID L Analysis
    • 4.2.4 COVID W Analysis

5. Companies Analysis

  • 5.1. Global Central Nervous System Therapeutics Market, Sales Area, Product Type
  • 5.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Central Nervous System Therapeutics Market
  • 5.3. Companies List

6. Exceutive Summary

7. Global Central Nervous System Therapeutics Market Forecast, 2021-2034, (USD Million)

  • 7.1. Global Central Nervous System Therapeutics Market

8. Global Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 8.1. Global Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 8.2. Global Central Nervous System Therapeutics Market by Disease (2028-2034)

9. Global Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2034), (USD Million)

  • 9.1. Global Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 9.2. Global Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

10. Global Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 10.1. Global Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 10.2. Global Central Nervous System Therapeutics Market by Drug Class (2028-2034)

11. Global Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 11.1. Global Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 11.2. Global Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

12. Global Central Nervous System Therapeutics Market by REGION (2021-2034), (USD Million)

  • 12.1. Global Central Nervous System Therapeutics Market by Region (2021-2027)
  • 12.2. Global Central Nervous System Therapeutics Market by Region (2028-2034)

13. North America Central Nervous System Therapeutics Market by Country (2021-2034), (USD Million)

  • 13.1. North America Central Nervous System Therapeutics Market by Country (2021-2027)
  • 13.2. North America Central Nervous System Therapeutics Market by Country (2028-2034)

14. North America Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 14.1. North America Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 14.2. North America Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 14.3. North America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 14.4. North America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

15. North America Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 15.1. North America Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 15.2. North America Central Nervous System Therapeutics Market by Drug Class (2028-2034)

16. North America Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 16.1. North America Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 16.2. North America Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

17. United States Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 17.1. United States Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 17.2. United States Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 17.3. United States Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 17.4. United States Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

18. United States Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 18.1. United States Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 18.2. United States Central Nervous System Therapeutics Market by Drug Class (2028-2034)

19. United States Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 19.1. United States Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 19.2. United States Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

20. Canada Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 20.1. Canada Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 20.2. Canada Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 20.3. Canada Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 20.4. Canada Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

21. Canada Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 21.1. Canada Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 21.2. Canada Central Nervous System Therapeutics Market by Drug Class (2028-2034)

22. Canada Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 22.1. Canada Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 22.2. Canada Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

23. Europe Central Nervous System Therapeutics Market by Country (2021-2034), (USD Million)

  • 23.1. Europe Central Nervous System Therapeutics Market by Country (2021-2027)
  • 23.2. Europe Central Nervous System Therapeutics Market by Country (2028-2034)

24. Europe Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 24.1. Europe Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 24.2. Europe Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 24.3. Europe Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 24.4. Europe Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

25. Europe Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 25.1. Europe Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 25.2. Europe Central Nervous System Therapeutics Market by Drug Class (2028-2034)

26. Europe Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 26.1. Europe Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 26.2. Europe Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

27. United Kingdom Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 27.1. United Kingdom Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 27.2. United Kingdom Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 27.3. United Kingdom Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 27.4. United Kingdom Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

28. United Kingdom Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 28.1. United Kingdom Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 28.2. United Kingdom Central Nervous System Therapeutics Market by Drug Class (2028-2034)

29. United Kingdom Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 29.1. United Kingdom Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 29.2. United Kingdom Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

30. Germany Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 30.1. Germany Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 30.2. Germany Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 30.3. Germany Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 30.4. Germany Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

31. Germany Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 31.1. Germany Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 31.2. Germany Central Nervous System Therapeutics Market by Drug Class (2028-2034)

32. Germany Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 32.1. Germany Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 32.2. Germany Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

33. France Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 33.1. France Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 33.2. France Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 33.3. France Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 33.4. France Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

34. France Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 34.1. France Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 34.2. France Central Nervous System Therapeutics Market by Drug Class (2028-2034)

35. France Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 35.1. France Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 35.2. France Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

36. Spain Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 36.1. Spain Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 36.2. Spain Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 36.3. Spain Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 36.4. Spain Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

37. Spain Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 37.1. Spain Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 37.2. Spain Central Nervous System Therapeutics Market by Drug Class (2028-2034)

38. Spain Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 38.1. Spain Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 38.2. Spain Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

39. Italy Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 39.1. Italy Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 39.2. Italy Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 39.3. Italy Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 39.4. Italy Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

40. Italy Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 40.1. Italy Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 40.2. Italy Central Nervous System Therapeutics Market by Drug Class (2028-2034)

41. Italy Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 41.1. Italy Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 41.2. Italy Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

42. Netherlands Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 42.1. Netherlands Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 42.2. Netherlands Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 42.3. Netherlands Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 42.4. Netherlands Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

43. Netherlands Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 43.1. Netherlands Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 43.2. Netherlands Central Nervous System Therapeutics Market by Drug Class (2028-2034)

44. Netherlands Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 44.1. Netherlands Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 44.2. Netherlands Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

45. Russia Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 45.1. Russia Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 45.2. Russia Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 45.3. Russia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 45.4. Russia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

46. Russia Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 46.1. Russia Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 46.2. Russia Central Nervous System Therapeutics Market by Drug Class (2028-2034)

47. Russia Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 47.1. Russia Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 47.2. Russia Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

48. Rest of Europe Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 48.1. Rest of Europe Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 48.2. Rest of Europe Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 48.3. Rest of Europe Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 48.4. Rest of Europe Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

49. Rest of Europe Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 49.1. Rest of Europe Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 49.2. Rest of Europe Central Nervous System Therapeutics Market by Drug Class (2028-2034)

50. Rest of Europe Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 50.1. Rest of Europe Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 50.2. Rest of Europe Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

51. Asia Pacific Central Nervous System Therapeutics Market by Country (2021-2034), (USD Million)

  • 51.1. Asia Pacific Central Nervous System Therapeutics Market by Country (2021-2027)
  • 51.2. Asia Pacific Central Nervous System Therapeutics Market by Country (2028-2034)

52. Asia Pacific Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 52.1. Asia Pacific Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 52.2. Asia Pacific Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 52.3. Asia Pacific Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 52.4. Asia Pacific Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

53. Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 53.1. Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 53.2. Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2028-2034)

54. Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 54.1. Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 54.2. Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

55. China Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 55.1. China Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 55.2. China Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 55.3. China Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 55.4. China Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

56. China Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 56.1. China Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 56.2. China Central Nervous System Therapeutics Market by Drug Class (2028-2034)

57. China Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 57.1. China Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 57.2. China Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

58. India Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 58.1. India Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 58.2. India Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 58.3. India Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 58.4. India Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

59. India Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 59.1. India Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 59.2. India Central Nervous System Therapeutics Market by Drug Class (2028-2034)

60. India Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 60.1. India Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 60.2. India Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

61. Japan Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 61.1. Japan Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 61.2. Japan Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 61.3. Japan Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 61.4. Japan Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

62. Japan Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 62.1. Japan Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 62.2. Japan Central Nervous System Therapeutics Market by Drug Class (2028-2034)

63. Japan Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 63.1. Japan Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 63.2. Japan Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

64. South Korea Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 64.1. South Korea Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 64.2. South Korea Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 64.3. South Korea Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 64.4. South Korea Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

65. South Korea Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 65.1. South Korea Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 65.2. South Korea Central Nervous System Therapeutics Market by Drug Class (2028-2034)

66. South Korea Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 66.1. South Korea Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 66.2. South Korea Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

67. Indonesia Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 67.1. Indonesia Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 67.2. Indonesia Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 67.3. Indonesia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 67.4. Indonesia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

68. Indonesia Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 68.1. Indonesia Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 68.2. Indonesia Central Nervous System Therapeutics Market by Drug Class (2028-2034)

69. Indonesia Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 69.1. Indonesia Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 69.2. Indonesia Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

70. Malaysia Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 70.1. Malaysia Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 70.2. Malaysia Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 70.3. Malaysia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 70.4. Malaysia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

71. Malaysia Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 71.1. Malaysia Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 71.2. Malaysia Central Nervous System Therapeutics Market by Drug Class (2028-2034)

72. Malaysia Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 72.1. Malaysia Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 72.2. Malaysia Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

73. Rest of Asia Pacific Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 73.1. Rest of Asia Pacific Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 73.2. Rest of Asia Pacific Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 73.3. Rest of Asia Pacific Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 73.4. Rest of Asia Pacific Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

74. Rest of Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 74.1. Rest of Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 74.2. Rest of Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2028-2034)

75. Rest of Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 75.1. Rest of Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 75.2. Rest of Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

76. Latin America Central Nervous System Therapeutics Market by Country (2021-2034), (USD Million)

  • 76.1. Latin America Central Nervous System Therapeutics Market by Country (2021-2027)
  • 76.2. Latin America Central Nervous System Therapeutics Market by Country (2028-2034)

77. Latin America Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 77.1. Latin America Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 77.2. Latin America Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 77.3. Latin America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 77.4. Latin America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

78. Latin America Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 78.1. Latin America Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 78.2. Latin America Central Nervous System Therapeutics Market by Drug Class (2028-2034)

79. Latin America Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 79.1. Latin America Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 79.2. Latin America Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

80. Brazil Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 80.1. Brazil Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 80.2. Brazil Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 80.3. Brazil Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 80.4. Brazil Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

81. Brazil Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 81.1. Brazil Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 81.2. Brazil Central Nervous System Therapeutics Market by Drug Class (2028-2034)

82. Brazil Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 82.1. Brazil Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 82.2. Brazil Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

83. Argentina Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 83.1. Argentina Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 83.2. Argentina Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 83.3. Argentina Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 83.4. Argentina Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

84. Argentina Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 84.1. Argentina Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 84.2. Argentina Central Nervous System Therapeutics Market by Drug Class (2028-2034)

85. Argentina Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 85.1. Argentina Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 85.2. Argentina Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

86. Mexico Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 86.1. Mexico Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 86.2. Mexico Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 86.3. Mexico Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 86.4. Mexico Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

87. Mexico Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 87.1. Mexico Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 87.2. Mexico Central Nervous System Therapeutics Market by Drug Class (2028-2034)

88. Mexico Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 88.1. Mexico Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 88.2. Mexico Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

89. Rest of Latin America Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 89.1. Rest of Latin America Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 89.2. Rest of Latin America Central Nervous System Therapeutics Market by Disease (2028-2034)
  • 89.3. Rest of Latin America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
  • 89.4. Rest of Latin America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

90. Rest of Latin America Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

  • 90.1. Rest of Latin America Central Nervous System Therapeutics Market by Drug Class (2021-2027)
  • 90.2. Rest of Latin America Central Nervous System Therapeutics Market by Drug Class (2028-2034)

91. Rest of Latin America Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

  • 91.1. Rest of Latin America Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
  • 91.2. Rest of Latin America Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

92. Middle East & Africa Central Nervous System Therapeutics Market by Country (2021-2034), (USD Million)

  • 92.1. Middle East & Africa Central Nervous System Therapeutics Market by Country (2021-2027)
  • 92.2. Middle East & Africa Central Nervous System Therapeutics Market by Country (2028-2034)

93. Middle East & Africa Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

  • 93.1. Middle East & Africa Central Nervous System Therapeutics Market by Disease (2021-2027)
  • 93.2. Middle East & Africa Central Nervous System Therapeutics Market
Show more
Product Code: PM5368

LIST OF TABLES

  • TABLE 1. Market SEGMENT
  • TABLE 2. Global Central Nervous System Therapeutics Market Growth Rate by Disease (USD Million) (2025-2034)
  • TABLE 3. Global Central Nervous System Therapeutics Market Growth Rate by Neurodegenerative Diseases (USD Million) (2025-2034)
  • TABLE 4. Global Central Nervous System Therapeutics Market Growth Rate by Drug Class (USD Million) (2025-2034)
  • TABLE 5. Global Central Nervous System Therapeutics Market Growth Rate by DISTRIBUTION CHANNEL (USD Million) (2025-2034)
  • TABLE 6. Global Central Nervous System Therapeutics Market - Market snapshot & key buying criteria, 2025 - 2034
  • TABLE 7. Global Central Nervous System Therapeutics MARKET SIZE (USD Million), (USD MILLION) (2021-2027)
  • TABLE 8. Global Central Nervous System Therapeutics MARKET SIZE (USD Million), (USD MILLION) (2028-2034)
  • TABLE 9. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY DISEASE, (2021-2027)
  • TABLE 10. Global Central Nervous System Therapeutics Market SHARE BY DISEASE, (2021-2027)
  • TABLE 11. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY DISEASE, (2028-2034)
  • TABLE 12. Global Central Nervous System Therapeutics Market SHARE BY DISEASE, (2028-2034)
  • TABLE 13. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY NEURODEGENERATIVE DISEASES, (2021-2027)
  • TABLE 14. Global Central Nervous System Therapeutics Market SHARE BY NEURODEGENERATIVE DISEASES, (2021-2027)
  • TABLE 15. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY NEURODEGENERATIVE DISEASES, (2028-2034)
  • TABLE 16. Global Central Nervous System Therapeutics Market SHARE BY NEURODEGENERATIVE DISEASES, (2028-2034)
  • TABLE 17. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY DRUG CLASS, (2021-2027)
  • TABLE 18. Global Central Nervous System Therapeutics Market SHARE BY DRUG CLASS, (2021-2027)
  • TABLE 19. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY DRUG CLASS, (2028-2034)
  • TABLE 20. Global Central Nervous System Therapeutics Market SHARE BY DRUG CLASS, (2028-2034)
  • TABLE 21. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY DISTRIBUTION CHANNEL, (2021-2027)
  • TABLE 22. Global Central Nervous System Therapeutics Market SHARE BY DISTRIBUTION CHANNEL, (2021-2027)
  • TABLE 23. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY DISTRIBUTION CHANNEL, (2028-2034)
  • TABLE 24. Global Central Nervous System Therapeutics Market SHARE BY DISTRIBUTION CHANNEL, (2028-2034)
  • TABLE 25. Global Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Region, (2021-2027)
  • TABLE 26. Global Central Nervous System Therapeutics Market SHARE BY Region, (2021-2027)
  • TABLE 27. Global Central Nervous System Therapeutics marke SIZE BY Region, (2028-2034)
  • TABLE 28. Global Central Nervous System Therapeutics Market SHARE BY Region, (2028-2034)
  • TABLE 29. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2021-2027)
  • TABLE 30. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2028-2034)
  • TABLE 31. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 32. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 33. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 34. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 35. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 36. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 37. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 38. North America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 39. United States Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 40. United States Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 41. United States Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 42. United States Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 43. United States Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 44. United States Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 45. United States Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 46. United States Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 47. Canada Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 48. Canada Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 49. Canada Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 50. Canada Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 51. Canada Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 52. Canada Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 53. Canada Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 54. Canada Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 55. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2021-2027)
  • TABLE 56. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2028-2034)
  • TABLE 57. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 58. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 59. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 60. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 61. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 62. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 63. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 64. Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 65. United Kingdom Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 66. United Kingdom Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 67. United Kingdom Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 68. United Kingdom Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 69. United Kingdom Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 70. United Kingdom Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 71. United Kingdom Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 72. United Kingdom Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 73. Germany Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 74. Germany Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 75. Germany Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 76. Germany Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 77. Germany Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 78. Germany Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 79. Germany Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 80. Germany Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 81. France Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 82. France Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 83. France Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 84. France Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 85. France Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 86. France Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 87. France Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 88. France Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 89. Spain Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 90. Spain Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 91. Spain Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 92. Spain Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 93. Spain Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 94. Spain Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 95. Spain Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 96. Spain Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 97. Italy Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 98. Italy Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 99. Italy Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 100. Italy Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 101. Italy Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 102. Italy Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 103. Italy Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 104. Italy Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 105. Netherlands Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 106. Netherlands Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 107. Netherlands Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 108. Netherlands Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 109. Netherlands Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 110. Netherlands Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 111. Netherlands Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 112. Netherlands Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 113. Russia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 114. Russia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 115. Russia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 116. Russia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 117. Russia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 118. Russia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 119. Russia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 120. Russia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 121. Rest of Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 122. Rest of Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 123. Rest of Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 124. Rest of Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 125. Rest of Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 126. Rest of Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 127. Rest of Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 128. Rest of Europe Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 129. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2021-2027)
  • TABLE 130. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2028-2034)
  • TABLE 131. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 132. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 133. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 134. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 135. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 136. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 137. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 138. Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 139. China Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 140. China Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 141. China Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 142. China Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 143. China Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 144. China Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 145. China Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 146. China Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 147. India Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 148. India Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 149. India Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 150. India Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 151. India Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 152. India Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 153. India Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 154. India Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 155. Japan Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 156. Japan Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 157. Japan Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 158. Japan Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 159. Japan Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 160. Japan Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 161. Japan Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 162. Japan Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 163. South Korea Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 164. South Korea Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 165. South Korea Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 166. South Korea Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 167. South Korea Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 168. South Korea Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 169. South Korea Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 170. South Korea Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 171. Indonesia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 172. Indonesia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 173. Indonesia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 174. Indonesia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 175. Indonesia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 176. Indonesia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 177. Indonesia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 178. Indonesia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 179. Malaysia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 180. Malaysia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 181. Malaysia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 182. Malaysia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 183. Malaysia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 184. Malaysia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 185. Malaysia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 186. Malaysia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 187. Rest of Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 188. Rest of Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 189. Rest of Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 190. Rest of Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 191. Rest of Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 192. Rest of Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 193. Rest of Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 194. Rest of Asia Pacific Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 195. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2021-2027)
  • TABLE 196. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2028-2034)
  • TABLE 197. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 198. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 199. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 200. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 201. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 202. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 203. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 204. Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 205. Brazil Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 206. Brazil Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 207. Brazil Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 208. Brazil Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 209. Brazil Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 210. Brazil Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 211. Brazil Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 212. Brazil Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 213. Argentina Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 214. Argentina Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 215. Argentina Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 216. Argentina Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 217. Argentina Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 218. Argentina Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 219. Argentina Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 220. Argentina Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 221. Mexico Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 222. Mexico Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 223. Mexico Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 224. Mexico Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 225. Mexico Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 226. Mexico Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 227. Mexico Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 228. Mexico Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 229. Rest of Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 230. Rest of Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 231. Rest of Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 232. Rest of Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 233. Rest of Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 234. Rest of Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 235. Rest of Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 236. Rest of Latin America Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 237. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2021-2027)
  • TABLE 238. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Country, (2028-2034)
  • TABLE 239. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 240. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 241. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 242. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 243. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 244. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 245. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 246. Middle East & Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 247. Saudi Arabia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 248. Saudi Arabia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 249. Saudi Arabia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 250. Saudi Arabia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 251. Saudi Arabia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 252. Saudi Arabia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 253. Saudi Arabia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 254. Saudi Arabia Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 255. UAE Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 256. UAE Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 257. UAE Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 258. UAE Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 259. UAE Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 260. UAE Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 261. UAE Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 262. UAE Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 263. South Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 264. South Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 265. South Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 266. South Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 267. South Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 268. South Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 269. South Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 270. South Africa Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 271. Israel Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2021-2027)
  • TABLE 272. Israel Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Disease, (2028-2034)
  • TABLE 273. Israel Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2021-2027)
  • TABLE 274. Israel Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Neurodegenerative Diseases, (2028-2034)
  • TABLE 275. Israel Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2021-2027)
  • TABLE 276. Israel Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Drug Class, (2028-2034)
  • TABLE 277. Israel Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2021-2027)
  • TABLE 278. Israel Central Nervous System Therapeutics MARKET SIZE (USD Million) BY Distribution Channel, (2028-2034)
  • TABLE 279. Rest of Middle East & Africa Central Nervous System Therapeutics MARKET
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!